Toll Free: 1-888-928-9744

Pantarhei Bioscience BV - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Pantarhei Bioscience BV - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Pantarhei Bioscience BV - Product Pipeline Review - 2014', provides an overview of the Pantarhei Bioscience BV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pantarhei Bioscience BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Pantarhei Bioscience BV including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Pantarhei Bioscience BV's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Pantarhei Bioscience BV's pipeline products

Reasons to buy

- Evaluate Pantarhei Bioscience BV's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Pantarhei Bioscience BV in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Pantarhei Bioscience BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Pantarhei Bioscience BV and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pantarhei Bioscience BV
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Pantarhei Bioscience BV and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Pantarhei Bioscience BV Snapshot 5
Pantarhei Bioscience BV Overview 5
Key Information 5
Key Facts 5
Pantarhei Bioscience BV - Research and Development Overview 6
Key Therapeutic Areas 6
Pantarhei Bioscience BV - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Pantarhei Bioscience BV - Pipeline Products Glance 14
Pantarhei Bioscience BV - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Pantarhei Bioscience BV - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Pantarhei Bioscience BV - Drug Profiles 17
(dehydroepiandrosterone + estradiol + progesterone) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
(estrogen + progesterone) 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
(oxytocin + estrogen) 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
BLACE 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Recombinant Protein for Ovarian Cancer 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
T-2 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Pantarhei Bioscience BV - Pipeline Analysis 25
Pantarhei Bioscience BV - Pipeline Products by Target 25
Pantarhei Bioscience BV - Pipeline Products by Route of Administration 26
Pantarhei Bioscience BV - Pipeline Products by Molecule Type 27
Pantarhei Bioscience BV - Pipeline Products by Mechanism of Action 28
Pantarhei Bioscience BV - Recent Pipeline Updates 29
Pantarhei Bioscience BV - Dormant Projects 30
Pantarhei Bioscience BV - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33
List of Tables
Pantarhei Bioscience BV, Key Information 5
Pantarhei Bioscience BV, Key Facts 5
Pantarhei Bioscience BV - Pipeline by Indication, 2014 8
Pantarhei Bioscience BV - Pipeline by Stage of Development, 2014 9
Pantarhei Bioscience BV - Monotherapy Products in Pipeline, 2014 10
Pantarhei Bioscience BV - Combination Treatment Modalities in Pipeline, 2014 11
Pantarhei Bioscience BV - Partnered Products in Pipeline, 2014 12
Pantarhei Bioscience BV - Partnered Products/ Combination Treatment Modalities, 2014 13
Pantarhei Bioscience BV - Phase II, 2014 14
Pantarhei Bioscience BV - Phase I, 2014 15
Pantarhei Bioscience BV - Preclinical, 2014 16
Pantarhei Bioscience BV - Pipeline by Target, 2014 25
Pantarhei Bioscience BV - Pipeline by Route of Administration, 2014 26
Pantarhei Bioscience BV - Pipeline by Molecule Type, 2014 27
Pantarhei Bioscience BV - Pipeline Products by Mechanism of Action, 2014 28
Pantarhei Bioscience BV - Recent Pipeline Updates, 2014 29
Pantarhei Bioscience BV - Dormant Developmental Projects,2014 30
Pantarhei Bioscience BV, Other Locations 31 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify